ORIC Pharmaceuticals Investors

32 investors on Angel Roster list ORIC Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Israel and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name ORIC Pharmaceuticals can appear together.

Investors listed
32
With verified email
53%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 32 ORIC Pharmaceuticals investors

The most complete profiles first. Showing 32 of 32.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • David GoeddelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan LimVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: Black Diamond Therapeutics, Ignyta, Flex Pharma, Independa and 6 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Peter SvennilsonVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Oleg NodelmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Sarah MarriottVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Scott PlatshonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Seiji M.

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure and 7 more

    Contact details available

  • Takaaki Ishii

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure and 7 more

    Contact details available

  • Tim Kutzkey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Caroline Stout

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • JJ Kang

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • James Evangelista

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

Frequently asked questions

How many ORIC Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 32 ORIC Pharmaceuticals investors. 17 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (25), Private Equity Firms (24) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ORIC Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (18), Series A (5) and Series B (1).

Where are ORIC Pharmaceuticals investors based?

Most are based in the United States (28), Israel (2) and the United Kingdom (1).

Which companies have ORIC Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Decibel Therapeutics (20), Arcus Biosciences (18), Syros Pharmaceuticals (17), Olema Oncology (17) and Scorpion Therapeutics (17).

How do I contact ORIC Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 32, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.